Cellectar Biosciences, Inc. — Director's Dealing 2016

May 24, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cellectar Biosciences, Inc. (CLRB)
CIK: 0001279704
Period of Report: 2016-05-12

Reporting Person: CARUSO JAMES V (Director, President and CEO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-05-12	Stock option (right to buy)	$1.48	A	200000	Acquired	2026-05-12	Common Stock (200000)	Direct

Footnotes

F1: Options are not exercisable until stockholder approval of the increase of shares available for issuance under the plan. Options vest in equal quarterly increments over a period of three years from the date of grant.